Health: The partnership underscores Medtronic's commitment to integrating innovative technologies that address stroke challenges in India with local solutions. Qure's comprehensive set of solutions, qER and the Qure app, are designed to help clinicians streamline the stroke care pathway for patients.
- Artificial Intelligence (AI) in India
- Advanced stroke management using AI
India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT), today announced a partnership with Qure.ai to integrate artificial intelligence (AI) for improved stroke management in India. The partnership combines Medtronic's leadership in neuroscience and Qure's AI-enabled innovation. The collaboration aims to provide AI solutions to comprehensive stroke centers and primary stroke centers and will establish a hub and spoke network connected through technology. This network helps in faster identification, decision making and triage of stroke patients, thus facilitating better patient outcomes.
A stroke is a medical emergency in which blood flow to the brain is blocked. In many cases, stroke patients are unable to receive proper treatment on time due to lack of symptom awareness and structured patient pathways. In some cases, lack of specific physician training to correctly interpret CT scans delays referral of patients to a stroke preparedness center and increases stroke patient mortality and morbidity.
Qure's comprehensive suite of solutions, qER and the Qure app, are specifically designed to assist clinicians in streamlining the stroke care pathway for patients. qER provides quick reading and interpretation of head CT scans along with other vital parameters. All information is recorded in the Qure app, which is a platform for communication and bringing together different field teams from different hospitals. According to public records1 the time to read and diagnose a head CT using qER has decreased from ~65 minutes to ~2 minutes.
"Medtronic is working towards a future where stroke can be diagnosed quickly and treated effectively to potentially save a patient's life. By introducing AI, it will personalize healthcare technology in real-time. Stroke by making rapid decision-making, streamlining data sharing between two hospitals and improving efficiency." We are thrilled to collaborate with Qure.ai to support surgeons in diagnosis and treatment,” opined Michael Blackwell, Vice President and Managing Director, Medtronic India.
Commenting on the partnership, Prashant Warrier, Co-Founder and CEO, Qure.ai, commented, "By teaming up with Medtronic India, we will integrate Qure.ai's suite of AI-powered neuro-critical solutions to more effectively diagnose and manage stroke. Our state-of-the-art technology Uses advanced algorithms to analyze medical images so that healthcare providers can make informed decisions with improved diagnostic accuracy and speed. Our collaboration will increase operational efficiency in hospitals, optimizing hub-and-spoke pathways. The partnership with Medtronic is another of our commitment to harnessing the power of AI to enhance patient care and provide equitable healthcare for all. is the main pillar.” said that.
In India, about 1.8 million patients suffer from stroke every year. Timing is of the essence in stroke treatment. Patients can be treated within a golden period of 4.5 hours and, in severe cases, up to 24 hours after the onset of symptoms. Assisting these patients from diagnosis to treatment using AI tools will help reduce delays and gaps in the management of stroke care, in an era where every minute counts. This will lead to effective referral and treatment of stroke patients in primary and secondary health facilities, especially in the hub and spoke network.
Comments
Post a Comment